Juan Sanchez | Vice President, Corporate Communications and Investor Relations |
Sharon Mates | Chairman and Chief Executive Officer |
Mark Neumann | Executive Vice President and Chief Commercial Officer |
Suresh Durgam | Executive Vice President Chief Medical Officer |
Larry Hineline | Senior Vice President and Chief Financial Officer |
Andrew Tsai | Jefferies |
Jessica Fye | JP Morgan |
Charles Duncan | Cantor Fitzgerald |
Brian Abrahams | RBC Capital Markets |
Mike DiFiore | Evercore |
Marc Goodman | SVB Securities |
Sumant Kulkarni | Canaccord |
Jason Gerberry | Bank of America |
Karin Jenkins | Goldman Sachs |
David Amsellem | Piper Sandler |
Good morning, ladies and gentlemen. And welcome to Intra-Cellular Therapies First Quarter Earnings Call. At this time, all participants are in a listen-only mode [Operator Instructions].
As a reminder, today’s conference call is being recorded. I’d now like to turn the conference over to Dr.